Ariel Graff‐Guerrero

11.5k total citations
239 papers, 7.2k citations indexed

About

Ariel Graff‐Guerrero is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ariel Graff‐Guerrero has authored 239 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Psychiatry and Mental health, 83 papers in Cognitive Neuroscience and 60 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ariel Graff‐Guerrero's work include Schizophrenia research and treatment (77 papers), Functional Brain Connectivity Studies (59 papers) and Neurotransmitter Receptor Influence on Behavior (32 papers). Ariel Graff‐Guerrero is often cited by papers focused on Schizophrenia research and treatment (77 papers), Functional Brain Connectivity Studies (59 papers) and Neurotransmitter Receptor Influence on Behavior (32 papers). Ariel Graff‐Guerrero collaborates with scholars based in Canada, Japan and United States. Ariel Graff‐Guerrero's co-authors include Philip Gerretsen, Gary Remington, Fernando Caravaggio, Shinichiro Nakajima, Eric Plitman, David C. Mamo, Yusuke Iwata, Bruce G. Pollock, Hiroyuki Uchida and Camilo de la Fuente‐Sandoval and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and NeuroImage.

In The Last Decade

Ariel Graff‐Guerrero

233 papers receiving 7.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariel Graff‐Guerrero Canada 48 3.1k 2.2k 1.7k 1.1k 1.0k 239 7.2k
Birte Glenthøj Denmark 44 3.6k 1.2× 2.5k 1.1× 1.5k 0.9× 725 0.6× 827 0.8× 242 7.1k
Robert A. McCutcheon United Kingdom 31 2.7k 0.8× 1.5k 0.7× 1.5k 0.9× 1.3k 1.2× 546 0.5× 118 6.4k
Romina Mizrahi Canada 45 2.3k 0.7× 1.2k 0.5× 1.7k 1.0× 1.9k 1.7× 535 0.5× 155 6.8k
William M. McDonald United States 52 3.2k 1.0× 3.3k 1.5× 1.7k 1.0× 1.2k 1.0× 829 0.8× 161 11.7k
Gianfranco Spalletta Italy 58 3.5k 1.1× 3.6k 1.6× 1.3k 0.8× 919 0.8× 1.8k 1.7× 269 11.3k
Tarek K. Rajji Canada 52 3.3k 1.1× 3.7k 1.7× 896 0.5× 472 0.4× 1.2k 1.1× 313 8.5k
Tiago Reis Marques United Kingdom 37 2.2k 0.7× 1.3k 0.6× 1.1k 0.6× 1.2k 1.1× 633 0.6× 112 5.5k
James Stone United Kingdom 46 2.1k 0.7× 2.1k 0.9× 2.8k 1.6× 1.7k 1.5× 943 0.9× 164 8.6k
Benício N. Frey Canada 52 4.0k 1.3× 1.7k 0.8× 1.1k 0.6× 2.2k 1.9× 466 0.4× 303 9.1k
Miquel Bernardo Spain 49 5.5k 1.8× 1.7k 0.8× 745 0.4× 1.3k 1.1× 670 0.6× 406 8.8k

Countries citing papers authored by Ariel Graff‐Guerrero

Since Specialization
Citations

This map shows the geographic impact of Ariel Graff‐Guerrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Graff‐Guerrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Graff‐Guerrero more than expected).

Fields of papers citing papers by Ariel Graff‐Guerrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Graff‐Guerrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Graff‐Guerrero. The network helps show where Ariel Graff‐Guerrero may publish in the future.

Co-authorship network of co-authors of Ariel Graff‐Guerrero

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Graff‐Guerrero. A scholar is included among the top collaborators of Ariel Graff‐Guerrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Graff‐Guerrero. Ariel Graff‐Guerrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stogios, Nicolette, et al.. (2025). 547. The Dysregulation of the Glymphatic System in Patients With Psychosis Spectrum Disorders Minimally Exposed to Antipsychotics. Biological Psychiatry. 97(9). S323–S324. 1 indexed citations
2.
3.
4.
Ueno, Fumihiko, Vincenzo De Luca, Bruce G. Pollock, et al.. (2023). Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment. Medical Hypotheses. 175. 111068–111068. 1 indexed citations
5.
Chen, Robert, et al.. (2023). Tau in Atypical Parkinsonisms: A Meta‐Analysis of in Vivo PET Imaging Findings. Movement Disorders Clinical Practice. 10(12). 1725–1737. 2 indexed citations
6.
Stogios, Nicolette, Marcos Sanches, Valerie Powell, et al.. (2022). Metformin for the prevention of clozapine‐induced weight gain: A retrospective naturalistic cohort study. Acta Psychiatrica Scandinavica. 146(3). 190–200. 14 indexed citations
7.
Kumar, Sanjeev, Amer M. Burhan, Philip Gerretsen, et al.. (2022). Impact of standardizing care for agitation in dementia using an integrated care pathway on an inpatient geriatric psychiatry unit. International Psychogeriatrics. 34(10). 919–928. 2 indexed citations
8.
Smith, Emily R., Raghunath Singh, Ariel Graff‐Guerrero, et al.. (2021). Adiposity in schizophrenia: A systematic review and meta‐analysis. Acta Psychiatrica Scandinavica. 144(6). 524–536. 20 indexed citations
9.
Kim, Julia, Lena C. Quilty, Peter Selby, et al.. (2021). A Measure to Assess Illness Awareness in Problem Gambling: Gambling Awareness and Insight Scale (GAS). Journal of Gambling Studies. 38(3). 1029–1043. 7 indexed citations
10.
Iwata, Yusuke, Shinichiro Nakajima, Eric Plitman, et al.. (2021). Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant Schizophrenia. Schizophrenia Bulletin Open. 2(1). sgab006–sgab006. 22 indexed citations
11.
Blázquez, Ferran Padrós, et al.. (2021). Psychometric properties of Gaudiebility Scale (Modulators of Enjoyment) for Children and Adolescents (GSCA). SHILAP Revista de lepidopterología.
12.
Noda, Yoshihiro, Ryosuke Tarumi, Shiori Honda, et al.. (2020). White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 100. 109871–109871. 22 indexed citations
13.
Ogyu, Kamiyu, Yoshihiro Noda, Kazunari Yoshida, et al.. (2020). Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia. Neuropsychopharmacology Reports. 40(2). 138–149. 5 indexed citations
14.
Bani‐Fatemi, Ali, Ariel Graff‐Guerrero, Philip Gerretsen, et al.. (2018). Structural and functional alterations of the suicidal brain: An updated review of neuroimaging studies. Psychiatry Research Neuroimaging. 278. 77–91. 77 indexed citations
15.
Davies, Simon, Amer M. Burhan, Philip Gerretsen, et al.. (2018). Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia. Journal of Psychopharmacology. 32(5). 509–523. 85 indexed citations
16.
Caravaggio, Fernando, Carol Borlido, Alan A. Wilson, & Ariel Graff‐Guerrero. (2015). Examining endogenous dopamine in treated schizophrenia using [11C]-(+)-PHNO positron emission tomography: A pilot study. Clinica Chimica Acta. 449. 60–62. 27 indexed citations
17.
Nakajima, Shinichiro, Hiroyuki Uchida, Robert R. Bies, et al.. (2015). Dopamine D2/3Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia Bulletin. 42(1). sbv106–sbv106. 18 indexed citations
18.
Fuente‐Sandoval, Camilo de la, Francisco Reyes-Madrigal, Xiangling Mao, et al.. (2015). Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy. The International Journal of Neuropsychopharmacology. 19(3). pyv105–pyv105. 65 indexed citations
19.
Uchida, Hiroyuki, Robert R. Bies, Takefumi Suzuki, et al.. (2014). Predicting dopamine D2 receptor occupancy following antipsychotic dose reduction: a pilot PET study.. 34(2). 55–56. 1 indexed citations
20.
Suzuki, Takefumi, G. Remington, Robert R. Bies, et al.. (2013). Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study. Schizophrenia Bulletin. 39(5). 993–998. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birte Glenthøj Breakdown of academic impact, for papers by Robert A. McCutcheon Breakdown of academic impact, for papers by Romina Mizrahi Breakdown of academic impact, for papers by William M. McDonald Breakdown of academic impact, for papers by Gianfranco Spalletta Breakdown of academic impact, for papers by Tarek K. Rajji Breakdown of academic impact, for papers by Tiago Reis Marques Breakdown of academic impact, for papers by James Stone Breakdown of academic impact, for papers by Benício N. Frey Breakdown of academic impact, for papers by Miquel Bernardo
Rankless by CCL
2026